BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 406336)

  • 1. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.
    Durack DT; Starkebaum MK; Petersdorf RG
    J Lab Clin Med; 1977 Jul; 90(1):171-9. PubMed ID: 406336
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyelonephritis. XVII. Comparison of combinations of vancomycin, ampicillin, streptomycin, and gentamicin in the treatment of enterococcal infection in rats.
    Harwick HJ; Kalmanson GM; Guze LB
    J Infect Dis; 1974 Mar; 129(3):358-61. PubMed ID: 4205881
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA; Huycke M
    Arch Intern Med; 1989 Aug; 149(8):1873-5. PubMed ID: 2504123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcal endocarditis.
    Wilkowske CJ
    Mayo Clin Proc; 1982 Feb; 57(2):101-5. PubMed ID: 6798333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P; Brandimarte C; Martino P; Carlone S; Giunchi G
    Arch Intern Med; 1977 Nov; 137(11):1562-7. PubMed ID: 921443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.
    Guze PA; Kalmanson GM; Freedman LR; Ishida K; Guze LB
    Antimicrob Agents Chemother; 1983 Oct; 24(4):514-7. PubMed ID: 6418063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enterococcal endocarditis, a model of therapeutic difficulty].
    Fernández Guerrero ML; Núñez García A
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J; Kaye D
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
    Pelletier LL; Durack DT; Petersdorf RG
    J Clin Invest; 1975 Aug; 56(2):319-30. PubMed ID: 1150874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of vancomycin-resistant enterococcal endocarditis.
    Brink AJ; van den Ende J; Routier RJ; Devenish L
    S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
    [No Abstract]   [Full Text] [Related]  

  • 13. Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
    McDonald GR
    J Tenn Med Assoc; 1993 Dec; 86(12):527-8. PubMed ID: 8295423
    [No Abstract]   [Full Text] [Related]  

  • 14. Gentamicin-resistant enterococcal endocarditis: the need for routine screening for high-level resistance to aminoglycosides.
    Libertin CR; McKinley KM
    South Med J; 1990 Apr; 83(4):458-60. PubMed ID: 2108503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of enterococcal septicemia and endocarditis].
    Bengtsson E; Svanbom M; Tunevall G
    Lakartidningen; 1971 Mar; 68(10):1087-92. PubMed ID: 5573786
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
    Bayer AS; Tu J
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1068-74. PubMed ID: 2118323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
    Working P
    Heart; 1998 Feb; 79(2):207-10. PubMed ID: 9538323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of bacterial endocarditis].
    Jeljaszewicz J; Hryniewicz W
    Kardiol Pol; 1978; 21(5):475-8. PubMed ID: 101706
    [No Abstract]   [Full Text] [Related]  

  • 20. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.